CDC And Prevention Advisory Panel Backs Expanded Use Of Pfizer And Merck's Pneumococcal Vaccines

US CDC AdCom recommends lowering the age for pneumococcal vaccines

Merck (MRK): Patent Concerns and Earnings Forecast Cuts Impact Dow Performance

Analysts Estimate Merck (MRK) to Report a Decline in Earnings: What to Look Out for

CDC’S ACIP Recommends Merck’s CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Adults 50 Years of Age and Older

800% Upside For This Biotech Stock - Analyst Initiates Coverage On Bladder Cancer Focused ImmunityBio

Is Merck & Co., Inc. (NYSE:MRK) the Most Undervalued Value Stock to Buy According to Analysts?

Merck acquires cancer drug startup; Elevidys ex-US sales rise

Merck (MRK) Advances While Market Declines: Some Information for Investors

The Zacks Analyst Blog Highlights Visa, Netflix, Merck and Hovnanian

Top Research Reports for Visa, Netflix & Merck

Gilead Sciences/Merck's Investigational Once-Weekly HIV Combo Therapy Shows Sustained Virus Suppression To 48 Weeks